Table 1.
Variable | Lesion group (n = 60) | Non-lesion group (n = 32) | Pa value |
---|---|---|---|
Age, y | 33.48 ± 8.37 | 35.28 ± 9.88 | 0.360b |
Sex | 0.827c | ||
Male | 38 | 21 | |
Female | 22 | 11 | |
BMI, kg/m2 | 24.71 ± 2.78 | 24.03 ± 2.71 | 0.266b |
VAS | 6.08 ± 1.64 | 6.25 ± 2.00 | 0.668b |
AOFAS | 69.72 ± 9.29 | 71.79 ± 9.70 | 0.278b |
KAFS | 66.42 ± 8.58 | 67.91 ± 11.36 | 0.519b |
ATT, mm | 7.42 ± 1.80 | 7.22 ± 1.31 | 0.584b |
Disease duration, mo | 16.13 ± 3.23 | 15.63 ± 2.92 | 0.459b |
BMI, Body mass index; OCD, osteochondral defect; VAS, Visual Analogue Scale; AOFAS, American Orthopaedic Foot and Ankle Society; KAFS, Karlsson Ankle Function Score; ATT, Anterior Talar Translation
aA value p < 0.05 was set as statistically significant
bt test
cPearson χ2 test